Nutex Health Inc.
NUTXHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeNutex Health Inc. operates as a healthcare services and operations company in the United States. The $1.44B market capitalization puts NUTX squarely in small-cap range for its industry. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate.
Market Cap
$1.44B
Beta
2.00
P/E (TTM)
8.30
P/E (Fwd)
10.31
EPS (TTM)
$25.24
EPS (Fwd)
$20.33
ROE
64.6%
ROA
33.3%
Cash
$205.2M
Total Debt
$347.3M
Free CF
$130.7M
52W Change
61.9%
Annual Financials
Cash vs Debt
Where NUTX stands vs its 150-day and 200-day moving averages
As of the October 12, 2026 close, NUTX finished 36.19% above its 150-day moving average ($151.47) and 39.16% above its 200-day moving average ($148.24). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NUTX overbought or oversold?
At the October 12, 2026 close, NUTX's RSI(14) was 53.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, NUTX has $205.2M in cash with $347.3M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $130.7M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 64.6%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 33.3% further supports the picture of efficient asset utilization. Revenue has grown from $331.5M (2021) to $875.3M (2025), reflecting a 164% increase over the period.
A beta of 2.00 means NUTX is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing NUTX.